🔗 Link in bio to listen to the full podcast episode. 🎧 Antibody-drug conjugates(ADCs) are a relatively new type of medicine for breast cancer. Enhertu and Dato-DXd are two ADCs used to treat breast cancer. Dr Benjamin Schrank and colleagues have developed a new type of ADC that combines an antibody with a toxin — called an antibody-toxin conjugate — that teaches the immune system to recognize and attack cancer cells. In this podcast episode, Dr. Schrank explains: 🎙️ the antibody/ toxin compon